Researchers have hailed the dawn of a new era of Alzheimer’s therapies after a clinical trial confirmed that a drug slows cognitive decline in patients with early stages of the disease. The result comes after decades of failure in the field and encouraged experts to say Alzheimer’s – which affects 30 million people worldwide – could be treatable.
“This is the first drug that provides a real treatment option for Alzheimer patients,” said Bart De Strooper, director of the UK Dementia Research Institute at University College London (UCL).
